477259-00-0

Upstream product

• 223253-87-0 4-[2-(2,2,2-trifluoroacetamido)ethyl]benzenesulfonyl chloride 

Downstream Products

• 699013-01-9 ethyl 4-[[2-[2-[(trifluoroacetyl)amino]ethyl]phenyl]thio]-2-pyridinecarboxylate 
• 699013-02-0 ethyl 4-[[4-[2-[(trifluoroacetyl)amino]ethyl]phenyl]thio]-2-pyridinecarboxylate 
• 870104-62-4 2,2,2-trifluoro-N-[2-[4-[[3-(aminocarbonyl)-4-nitrophenyl]-sulfonyl]phenyl]ethyl]acetamide 
• 870104-61-3 2,2,2-trifluoro-N-[2-[4-[[3-(aminocarbonyl)-4-nitrophenyl]thio]phenyl]ethyl]acetamide 

Relevant academic research and scientific papers

Aminoalcohol derivatives

The present invention relates to a compound formula [I]: wherein R1 is hydrogen or halogen, R2 is hydrogen or an amino protective group, R3 is hydrogen or lower alkyl, X is bond, —CH2— or —O—, and Y is ?in which R4 is lower alkoxycarbonyl, ?in which R5 is carboxy(lower)alkyl, etc., ?in which R6 is hydroxy, etc., and so on, or a salt thereof. The compound [I] of the present invention and pharmaceutically acceptable salts thereof are useful for the prophylactic and/or the therapeutic treatment of pollakiurea or urinary incontinence.

AMINOALCOHOL DERIVATIVES AND THEIR USE AS BETA-3 ADRENERGIC RECEPTOR AGONISTS

The present invention relates to a compound formula [I] or a salt thereof. The compound [I] of the present invention and pharmaceutically acceptable salts thereof are useful for the prophylactic and/or the therapeutic treatment of pollakiurea or urinary incontinence.